BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 2879-2882

  Junkins, Alan D ^a   Lockhart, Shawn R ^a   Heilmann, Kristopher P ^a   Dohrn, Cassie L ^a   Von Stein, Diana L ^a   Winokur, Patricia L ^a   Doern, Gary V ^a   Richter, Sandra S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; OXACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CEFOXITIN; DIAGNOSTIC ERRORS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OXACILLIN; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 69949090646     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01109-09     Document Type: Article

References (16)

1. Berger-Bachi, B., and S. Rohrer. 2002. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol. 178:165-171.
2. Cauwelier, B., B. Gordts, P. Descheemaecker, and H. Van Landuyt. 2004. Evaluation of a disk diffusion method with cefoxitin (30 μg) for detection of methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 23:867-868.
3. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard, 8th ed. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. CLSI document M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Felten, A., B. Grandry, P. H. Lagrange, and I. Casin. 2002. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxolactam, the VITEK 2 system, and the MRSA-screen latex agglutination test. J. Clin. Microbiol. 40:2766-2771.
6. Fernandes, C. J., L. A. Fernandes, and P. Collignon on behalf of the Australian Group on Antimicrobial Resistance. 2005. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 55:506-510.
7. Food and Drug Administration. 2007. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for industry and FDA. Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/ oivd/guidance/631.html.
8. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
9. McKinney, T. K., V. K. Sharma, W. A. Craig, and G. L. Archer. 2001. Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and β-lactamase regulators. J. Bacteriol. 183:6862-6868.
10. Oliveira, D. C., and H. de Lencastré. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.
11. Roisin, S., C. Nonhoff, O. Denis, and M. J. Struelens. 2008. Evaluation of new VITEK 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. J. Clin. Microbiol. 46:2525-2528.
12. Sakoulas, G., H. S. Gold, L. Venkataraman, P. C. Degirolami, G. M. Eliopoulos, and Q. Qian. 2001. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J. Clin. Microbiol. 39:3946-3951.
13. Spanu, T., M. Sanguinetti, T. D'Inzeo, D. Ciccaglione, L. Romano, F. Leone, P. Mazzella, and G. Fadda. 2004. Identification of methicillin-resistant isolates of Staphylococcus aureus and coagulase-negative staphylococci responsible for bloodstream infections with the Phoenix™ system. Diagn. Microbiol. Infect. Dis. 48:221-227.
14. Swenson, J. M., D. Lonsway, S. McAllister, A. Thompson, L. Jevitt, W. Zhu, and J. B. Patel. 2007. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn. Microbiol. Infect. Dis. 58:33-39.
15. Swenson, J. M., F. C. Tenover, and the Cefoxitin Disk Study Group. 2005. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 43:3818-3823.
16. Velasco, D., M. del Mar Tomas, M. Cartelle, A. Beceiro, A. Perez, F. Molina, R. Moure, R. Villanueva, and G. Bou. 2005. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 55:379-382.